Andria Reyes
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Andria Reyes has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Elaine Fleck
Division of Community and Population Health, New York Presbyterian Hospital, New York, USA
1 shared publication - Gary K. Schwartz
Columbia University Irving Medical Center, New York, NY 10032, USA
1 shared publication - Grace Clarke Hillyer
Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, USA
1 shared publication - Karen M. Schmitt
Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, USA
1 shared publication - Mary Beth Terry
Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY 10032, USA
1 shared publication - Meaghan Nazareth
Mailman School of Public Health, Department of Epidemiology, Columbia University, New York, USA
1 shared publication
Latest Publications
- 13 October 2022
- Published by Springer Nature in Journal of Community Genetics
- Vol. 13 (6) , 605-617
Interest in genetic testing and risk-reducing behavioral changes: results from a community health assessment in New York City
Risk-based genetic tests are often used to determine cancer risk, when to initiate screening, and frequency of screening, but rely on interest in genetic testing. We examined overall interest in genetic testing for cancer risk assessment and willingness to change behavior, and whether these are affected by demographic or socioeconomic factors. We conducted a community needs health survey in 2019 among primary care and cancer patients, family members and community members in New York City. We used univariable analysis and relative risk regression to examine interest in genetic cancer risk testing and willingness to modify lifestyle behaviors in response to an informative genetic test. Of the 1225 participants, 74.0% (n = 906) expressed interest in having a genetic test to assess cancer risk. Interest in genetic testing was high across all demographic and socioeconomic groups; reported interest in genetic testing by group ranged from 65.0 (participants aged 65 years and older) to 83.6% (participants below federal poverty level). Among the 906 participants that reported interest in genetic testing, 79.6% were willing to change eating habits, 66.5% to change exercise habits, and 49.5% to lose weight in response to an informative genetic test result. Our study reveals that interest in genetic testing for cancer risk is high among patients and community members and is high across demographic and socioeconomic groups, as is the reported willingness to change behavior. Based on these results, we recommend that population-based genetic testing may result in greater reduction cancer risk, particularly among minoritized groups.
- 13 October 2022
- Published by Springer Nature in Journal of Community Genetics
- Vol. 13 (6) , 605-617
Interest in genetic testing and risk-reducing behavioral changes: results from a community health assessment in New York City
Risk-based genetic tests are often used to determine cancer risk, when to initiate screening, and frequency of screening, but rely on interest in genetic testing. We examined overall interest in genetic testing for cancer risk assessment and willingness to change behavior, and whether these are affected by demographic or socioeconomic factors. We conducted a community needs health survey in 2019 among primary care and cancer patients, family members and community members in New York City. We used univariable analysis and relative risk regression to examine interest in genetic cancer risk testing and willingness to modify lifestyle behaviors in response to an informative genetic test. Of the 1225 participants, 74.0% (n = 906) expressed interest in having a genetic test to assess cancer risk. Interest in genetic testing was high across all demographic and socioeconomic groups; reported interest in genetic testing by group ranged from 65.0 (participants aged 65 years and older) to 83.6% (participants below federal poverty level). Among the 906 participants that reported interest in genetic testing, 79.6% were willing to change eating habits, 66.5% to change exercise habits, and 49.5% to lose weight in response to an informative genetic test result. Our study reveals that interest in genetic testing for cancer risk is high among patients and community members and is high across demographic and socioeconomic groups, as is the reported willingness to change behavior. Based on these results, we recommend that population-based genetic testing may result in greater reduction cancer risk, particularly among minoritized groups.